Company: PHAT
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0000950170-25-057326
Chunk: 27

Company: Phathom Pharmaceuticals, Inc.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 27
---
      | — |     |            | — |     |                         | — |
| Asian                                   |     |        | — |     |    1 |   |     |            | — |     |                         | — |
| Hispanic or Latinx                      |     |        | — |     |      | — |     |            | — |     |                         | — |
| Native Hawaiian or Pacific Islander     |     |        | — |     |      | — |     |            | — |     |                         | — |
| White                                   |     |      2 |   |     |    6 |   |     |            | — |     |                         | — |
| Two or More Races or Ethnicities        |     |        | — |     |      | — |     |            | — |     |                         | — |
| LGBTQ+                                  |     |        | — |     |      | — |     |            | — |     |                         | — |
| Did Not Disclose Demographic Background |     |        | — |     |      | — |     |            | — |     |                         | — |

Anti-Hedging Policy Our insider trading policy expressly prohibits any of our employees, including our named executive officers, as well as our directors, from engaging in speculative transactions in our stock, including short sales, puts/calls, hedging transactions and margin accounts or pledges.

<div align='center'>16</div>

Compensation Committee Interlocks and Insider Participation

Mr. Cola (chairperson), Mr. Karbe (through February 29, 2024), Mr. Socks (commencing on February 29, 2024), Dr. Parikh, and Mr. Stenhouse served on our compensation committee during the 2024 fiscal year. None of the members of our compensation committee during the 2024 fiscal year has ever been one of our officers or employees. None of our executive officers currently serves, or has served, as a member of the board of directors or compensation committee of any entity that has one or more executive officers serving as a member of our board of directors or compensation committee.

Director Attendance at Annual Meetings

Although we do not have a formal policy regarding attendance by members of our board of directors at our annual meeting, we encourage all of our directors to attend, and all of our directors attended our 2024 annual meeting.

Communications with our Board of Directors

Stockholders seeking to communicate with our board of directors should